Market Overview

Zogenix to Host Conference Call Following FDA Panel Meeting, Will Be at 6:30PM

Related ZGNX
Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now
Zogenix Reports Positive Top-Line Results From Relday(TM) Phase 1b Multi-Dose Clinical Trial

Zogenix (NASDAQ: ZGNX) will host a conference call to discuss the outcome of the AADPAC meeting today, Friday, December 7, 2012 at 6:30 p.m. ET (3:30 p.m. PT). To participate, please dial (800) 299-9086 (U.S.) or (617) 786-2903 (International); participant passcode: 21970283.

Posted-In: News FDA


Related Articles (ZGNX)

Get Benzinga's Newsletters